FIELD: chemistry.
SUBSTANCE: invention relates to tetrahydroquinoline derivatives of formula 
(I), where values of C3-C4, R2, R3, R4, R5, L1, L2, Y and X are given in claim 1, as muscarinic receptor agonists; compositions containing said compounds; methods of inhibiting muscarinic receptor activity using said compounds; methods of treating diseased conditions associated with the muscarinic receptor using said compounds, and methods of identifying a subject suitable for treatment using said compounds.
EFFECT: improved properties of compounds.
22 cl, 1 tbl, 3 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| M1 MUSCARINE RECEPTOR AGONISTS FOR ANALGETIC THERAPY | 2004 |
|
RU2358735C2 |
| HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT | 2002 |
|
RU2292346C2 |
| SUBSTITUTED DERIVATIVES OF CYCLOHEXAN-1,4-DIAMINE, METHOD FOR THEIR PREPARING AND DRUG | 2002 |
|
RU2321579C2 |
| DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
| 1,2,4-TRIAZINE-6-ONE DERIVATIVES, INHIBITING HIV | 2005 |
|
RU2401833C2 |
| AMINOSUBSTITUTED DIARYL [a, d] CYCLOHEPTANE ANALOGUES AS MUSCARINIC AGONISTS AND METHOD OF TREATING PSYCHONEUROLOGICAL DISORDERS | 2004 |
|
RU2394030C2 |
| OESTROGEN RECEPTORS LIGANDS | 2012 |
|
RU2620375C9 |
| USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING INFLAMMATORY EYE DISEASES | 2014 |
|
RU2663911C2 |
| CONJUGATES OF BINDER (ADC) WITH KSP INHIBITORS | 2014 |
|
RU2698697C2 |
| MACROCYCLIC COMPOUNDS USED AS PHARMACEUTICAL PRODUCTS | 2003 |
|
RU2334744C2 |
